Business

DECN Discusses Its Panacea GenUltimate! TBG System, Offering Elite Performance And Premier Upgrade Path For 4+ Million Users Of Lifescan Ultra Meters

DECN Discusses Its Panacea GenUltimate! TBG System, Offering Elite Performance And Premier Upgrade Path For 4+ Million Users Of Lifescan Ultra Meters.

articleDecision Diagnostics CorpJanuary 17, 20195/company/decision-diagnostics/news/decn-discusses-its-panacea-genultimate-tbg-system-offering-elite-performance-and-premier-upgrade-path-for-4-million-users-of-lifescan-ultra-meters
DECN Discusses Its Panacea GenUltimate! TBG System, Offering Elite Performance And Premier Upgrade Path For 4+ Million Users Of Lifescan Ultra Meters

About this update from Decision Diagnostics Corp

[{"type":"text","content":"Company Has Also Agreed To Manufacture A House Brand Product For A "Big Box" And Will Provide A Forecast And Price Terms Once We Agree In Coming DaysLOS ANGELES, CA / ACCESSWIRE / January 17, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is a 17 year old diabetes focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for a growing brand of glucose test strips and meters as highly accurate alternatives for legacy diabetic, proprietary, and pet testing glucose test strips. The company's current portfolio of test strips includes its GenUltimate!, GenChoice!, GenSure!, and GenUltimate! TBG test strips, its Avantage! and Precise! Glucometers, and its PetSure! and GenUltimate! 4Pets testing products for dogs, cats and horses.Today the company wishes to share expounded details regarding its new GenUltimate! panacea technology which will be used in the manufacture of its current GenUltimate! glucose test strip, its GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats and horses, and the GenUltimate! TBG test strip and Precise meter, the company's panacea product designed to achieve a new standard in at-home diabetes testing. As recently reported, the Full Spread Electrode Technology has been implemented throughout the GenUltimate! product line. This technological innovation introduces the unique test strip flexibility to be used in conjunction with the Lifescan OneTouch Ultra meters as well as the new GenUltimate! TBD system. GenUltimate! capitalizes on improvements to existing manufacturing components, tooling and processes to improve performance across the Platinum/Lifescan family of OneTouch Ultra meters. Most importantly, however, the new GenUltimate! will now provide the vehicle for the over 4 million OneTouch users to upgrade their OneTouch Ultra systems directly to GenUltimate TBG.The GenUltimate! TBG Precise! meters will be sold in retail outlets and in the larger on-line marketplaces for $9.95. Users of the Platinum/Lifescan OneTouch Ultra meters will be offered the added value of the new Precise! meters together with a vial of GenUltimate! TBD test strips at no additional charge., in most cases providing an upgrade pa...

More updates from Decision Diagnostics Corp